|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print June 10, 2002
Am J Physiol Lung Cell Mol Physiol, 10.1152/ajplung.00063.2002
Submitted on February 19, 2002
Accepted on June 5, 2002
1 UPRES EA220, Laboratoire de Pharmacologie, 45 rue des Saint-Peres, 75006 Paris, Faculte de Medecine Paris-Ouest, UFR Biomedicale des Saint-Peres, Paris, France, Metropolitan; Service de Reanimation Medicale, 45 rue Leblanc 75908 Paris Cedex 15, Hopital Europeen Georges Pompidou, Paris, France, Metropolitan
2 UPRES EA220, Laboratoire de Pharmacologie, 45 rue des Saint-Peres, 75006 Paris, Faculte de Medecine Paris-Ouest, UFR Biomedicale des Saint-Peres, Paris, France, Metropolitan
3 Service de Reanimation Medicale, 45 rue Leblanc 75908 Paris Cedex 15, Hopital Europeen Georges Pompidou, Paris, France, Metropolitan
4 Sanofi Synthelabo Recherche, 371 Avenue du Pr Blayac, 34000 Montpellier, Montpellier, France, Metropolitan
* To whom correspondence should be addressed. E-mail: charles.advenier{at}wanadoo.fr.
Incubation of human distal bronchi from 48 patients with fenoterol (107 M, 15 h) induced sensitization characterized by an increase in maximal contraction to endothelin-1 (ET-1) and acetylcholine (ACh). Incubation of human bronchi with forskolin (10-6, 3.10-6 and 10-5 M), an adenylcyclase activator, reproduced sensitization to ET-1 and ACh. The sensitizing effect of fenoterol was inhibited by co-incubation with gliotoxin, an NF
B inhibitor, with dexamethasone, with indomethacin, a cyclo-oxygenase inhibitor, with GR 32191, a TP prostanoid receptor antagonist, with MK 476, a Cyst-LT1 leukotriene receptor antagonist, with SR 140333 + SR 48968 + SR 142801 (NK1, 2, 3 tachykinin receptor antagonists) ±HOE 140 (a bradykinin B2 receptor antagonist), with SB 203580, an inhibitor of the 38-kDa mitogen-activated protein kinase (p38MAPK) or with calphostin C, a protein kinase C (PKC) blocker. Our results suggest that chronic exposure to fenoterol involves proinflammatory effects mediated by NF
B and pathways implying leukotrienes, prostanoids, bradykinin, tachykinins, PKC and p38MAPK leading to the regulation of smooth muscle contraction to ET-1 and ACh.
This article has been cited by other articles:
![]() |
K. Mizuta, G. Gallos, D. Zhu, F. Mizuta, F. Goubaeva, D. Xu, R. A. Panettieri Jr., J. Yang, and C. W. Emala Sr. Expression and coupling of neurokinin receptor subtypes to inositol phosphate and calcium signaling pathways in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L523 - L534. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Giembycz and R. Newton Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways. Eur. Respir. J., June 1, 2006; 27(6): 1286 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Faisy, F. Pinto, C. Danel, E. Naline, P.-A. Risse, I. Leroy, D. Israel-Biet, J.-Y. Fagon, M.-L. Candenas, and C. Advenier beta2-Adrenoceptor Agonist Modulates Endothelin-1 Receptors in Human Isolated Bronchi Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 410 - 416. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |